Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0086543 (
cataract
)
29,165
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pediatric
cataract
is highly heterogeneous clinically and etiologically. While mostly isolated,
cataract
can be part of many multisystem disorders, further complicating the diagnostic process. In this study, we applied genomic tools in the form of a multi-gene panel as well as whole-exome sequencing on unselected cohort of pediatric
cataract
(166 patients from 74 families). Mutations in previously reported
cataract
genes were identified in 58% for a total of 43 mutations, including 15 that are novel. GEMIN4 was independently mutated in families with a syndrome of
cataract
, global developmental delay with or without renal involvement. We also highlight a recognizable syndrome that resembles galactosemia (a fulminant infantile liver disease with
cataract
) caused by biallelic mutations in CYP51A1. A founder mutation in RIC1 (KIAA1432) was identified in patients with
cataract
, brain atrophy, microcephaly with or without cleft lip and palate. For non-syndromic pediatric
cataract
, we map a novel locus in a multiplex consanguineous family on 4p15.32 where exome sequencing revealed a homozygous truncating mutation in TAPT1. We report two further candidates that are biallelically inactivated each in a single
cataract
family:
TAF1A
(
cataract
with global developmental delay) and WDR87 (non-syndromic
cataract
). In addition to positional mapping data, we use iSyTE developmental lens expression and gene-network analysis to corroborate the proposed link between the novel candidate genes and
cataract
. Our study expands the phenotypic, allelic and locus heterogeneity of pediatric
cataract
. The high diagnostic yield of clinical genomics supports the adoption of this approach in this patient group.
...
PMID:Novel phenotypes and loci identified through clinical genomics approaches to pediatric cataract. 2787 35